Selected Presentations by the NCI Director
NCI Director Dr. Norman E. Sharpless at the 60th American Society of Hematology (ASH) Annual Meeting and Exposition with ASH President Dr. Alexis A. Thompson.
Dr. Norman Sharpless delivers a variety of talks and briefings to the cancer community about strategic and scientific initiatives to advance cancer research and care.
Advisory Board Presentations
NCI Director’s Report
Clinical Trials and Translational Research Advisory Committee, November 4, 2020
NCI Director’s Report
Virtual Meeting of Frederick National Laboratory Advisory Committee, October 14, 2020
NCI Director's Report
Virtual National Cancer Advisory Board Meeting, September 2, 2020
NCI Director's Report
Virtual Meeting of Frederick National Laboratory Advisory Committee, July 13, 2020
NCI Director's Update
Virtual Joint Meeting of NCI Board of Scientific Advisors & National Cancer Advisory Board, June 15, 2020
NCI Director's Update
Virtual Meeting of Frederick National Laboratory Advisory Committee, May 21, 2020
NCI Director's Update
Virtual Meeting of NCI Board of Scientific Advisors, May 12, 2020
NCI Director’s Report
Virtual Joint Meeting of NCI Board of Scientific Advisors & National Cancer Advisory Board, April 9, 2020
NCI Director’s Report
Clinical Trials and Translational Research Advisory Committee, March 12, 2020
NCI Director's Report
Virtual National Cancer Advisory Board Meeting, February 11, 2020
NCI Director's Report
Joint Meeting of the National Cancer Advisory Board & Board of Scientific Advisors, December 3, 2019
NCI Director’s Report
Board of Scientific Advisors, March 25, 2019
NCI Director’s Update
Clinical Trials and Translational Research Advisory Committee, March 6, 2019
NCI Director’s Update
National Cancer Advisory Board Meeting, February 12, 2019
NCI Director’s Update
Joint Meeting of the National Cancer Advisory Board & Board of Scientific Advisors, December 4, 2018
NCI Director’s Update
Clinical Trials and Translational Research Advisory Committee, November 17, 2018
NCI Director’s Update
Frederick National Laboratory Advisory Committee, October 29, 2018
NCI Director's Report
National Cancer Advisory Board, August 14, 2018
NCI Director's Report
Joint Meeting of the National Cancer Advisory Board & Board of Scientific Advisors, June 26, 2018
NCI Director's Report
Frederick National Laboratory Advisory Committee, May 8, 2018
NCI Director’s Report
Board of Scientific Advisors, March 20, 2018
NCI Director’s Report
Clinical Trials and Translational Research Advisory Committee, March 7, 2018
NCI Director's Report
National Cancer Advisory Board, February 13, 2018
NCI Director's Report
Joint Meeting of the National Cancer Advisory Board & Board of Scientific Advisors, November 29, 2017
Selected Other Presentations
Cancer Grand Challenges: Launching a new era in cancer research and discovery
NCI and Cancer Research UK Cancer Grand Challenges Partnership, August 27, 2020
Managing the Now, Focused on the Future
American Association for Cancer Research Virtual Annual Meeting II, June 23, 2020
View the text of Dr. Sharpless's remarks
Special Session with the National Cancer Institute Director
60th American Society of Hematology Annual Meeting and Exposition, December 1, 2018
Patients I will Never Forget
The 2018 Hardesty Lecture, West Virginia University, October 18, 2018
The Power and Promise of Cancer Research
American Society of Clinical Oncology Annual Meeting, June 2, 2018
View the text of Dr. Sharpless's remarks
NCI's Role in Promoting Rural Cancer Control
Accelerating Rural Cancer Control Research Meeting, May 30, 2018
NCI and the Cancer Community: Focusing on Patients Through Innovative Research
American Association for Cancer Research Annual Meeting, April 16, 2018
View the text of Dr. Sharpless's remarks
Impressions of a New NCI Director
2nd Pediatric Precision Oncology Conference, March 5, 2018
Dr. Sharpless: Perspectives from the NCI Director
NCI Staff Town Hall, December 11, 2017